BOSTON, MA and RESEARCH TRIANGLE PARK, NC--(Marketwired - Jun 19, 2013) - Quanticate, a leading global data-focused clinical research organization (CRO) today announced the relocation of its U.S. office with a move to North Carolina's Research Triangle. This expansion follows a number of partnerships that are being developed with Top 10 pharmaceutical companies to provide global functional support, particularly in the areas of biostatistics and statistical programming.
"Due to a number of large-scale partnerships being awarded to Quanticate, we saw the need to expand our U.S. presence and relocate our U.S. headquarters to the Research Triangle in North Carolina," explained Daniel Chapple, Quanticate's Chief Commercial Officer. "This move provides us with the opportunity of operating within a scalable and growing business region dedicated to the life science industry," continued Chapple.
The Research Triangle Park is recognized as a growing business district and is booming with biotech and life science companies. The relocation of the U.S. corporate headquarters from Boston to North Carolina is part of a larger global initiative to continue to grow Quanticate's programming, statistics, medical writing, data management and pharmacovigilance operations. "Quanticate is already seen as a leader for data-related services within Europe, but with our recent and forecasted growth, we expect to cement our position in the US and Asia as a leading global data-focused CRO," confirmed David Underwood, Quanticate CEO and Chairman.
By moving to a new larger location, Quanticate will be ramping up its recruitment to support a number of large pharmaceutical clients with the use of its centralized service provision (CSP) approach by utilizing experts, technologies and office locations to provide optimal solutions. "By expanding our U.S. presence we are able to provide additional experienced lead resources in our tailored solutions to clients as well as provide efficiencies through our on-shore, near-shore and off-shore capabilities," said Chapple. Quanticate will be opening the North Carolina office in Q3 2013 while maintaining a presence in Boston.
Quanticate will be attending this year's DIA annual conference in Boston at booth 1560 and will be able to answer any questions with regards to their CRO services and the launch of its new Quackers campaign. Visitors can also pick-up a #Quackers4Quanticate duck from the booth, by typing #Quackers4Quanticate on Twitter, Instagram, Google or Facebook, or by visiting the company website at www.quanticate.com to find out more.
Quanticate, headquartered in the UK and USA, is a leading global Clinical Research Organization (CRO) primarily focused on the management, analysis and reporting of data from clinical trials and post-marketing surveillance. Our team has a passion for excellence and provides high quality, efficient outsourcing solutions for companies who need additional capacity or who want to outsource certain activities in their entirety. Clinical trial management and post-marketing services include scalable on-site and off-site clinical data management, biostatistics, clinical programming, PK/PD analysis, medical writing, pharmacovigilance and consultancy. Quanticate is the first CRO to introduce the Centralized Service Provision (CSP) approach to outsourcing supported by its data centralization and visualization tool for both single study and cross-study data analysis. Please visit the new website at www.quanticate.com for further information and access to white papers.
- Health Care Industry
- North Carolina
- pharmaceutical companies
Ripple Effect Communications